Drug Trial Radar · NCT06144710
SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus
Last checked: Nov 19, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Nov 10, 2023
Primary completion
Jan 7, 2026
Study completion Jan 7, 2026
Sponsor
- Lead sponsor
- Hangzhou Sumgen Biotech Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 22, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single dose in healthy volunteers and multiple doses of SG301 SC injection in participants with systemic lupus erythematosus (SLE).
Conditions
- Systemic Lupus Erythematosus (SLE)
Interventions
SG301 SC InjectionDrug
Subcutaneous injection every two weeks
SG301 SC PlaceboDrug
Subcutaneous injection every two weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-Emergent Adverse Events(Part A and Part B)Time frame: From baseline through the end of study. Part A: Average 2 months per subject, Part B: Average 5 months per subject.
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
Shenzhen People's Hospital
Shenzhen, Guangdong, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
Pingxiang People's Hospital
Pingxiang, Jiangxi, China
Shandong University Qilu Hospital
Jinan, Shandong, China
Jining First People's Hospital
Jining, Shandong, China
Huashan Hospital affiliated to Fudan University
Shanghai, Shanghai Municipality, China
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.